Overview

Study of BH4, a New and Simple Treatment of Mild PKU

Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The main purpose is to test whether treatment with BH4-tablets can replace the protein restrictive diet in patients with mild PKU caused by a certain frequent mutation.
Phase:
Phase 2
Details
Lead Sponsor:
The Kennedy Institute-National Eye Clinic
Collaborator:
Sygekassernes Helsefond